Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, JAK inhibitors are increasingly used as an addition to phototherapy for vitiligo, with studies showing enhanced repigmentation when combined with narrowband UVB.
Serum biomarkers show promise but are not yet accurate enough alone for early oral cancer detection; combining multiple biomarkers improves accuracy.
Yes, nivolumab plus ipilimumab provides a 5-year survival benefit for pleural mesothelioma, with 14% vs 6% survival rates compared to chemotherapy.
Yes, personalized swallowing rehab significantly improves swallowing ability, reduces feeding tube dependence, and shortens hospital stay after oral cancer surgery.
Yes, adding HITHOC to surgery modestly improves survival for pleural mesothelioma patients without raising early postoperative risk, based on recent meta-analyses.
Yes, immune microenvironment characterization helps identify immune subtypes and biomarkers to guide precision immunotherapy in thyroid cancer, especially for aggressive forms.
Yes, the Systemic Immune-Inflammation Index (SII) can help predict lymph node metastasis in thyroid cancer, with studies showing moderate diagnostic accuracy.
Yes, the gut microbiome likely influences thyroid cancer development through immune regulation, hormone metabolism, and metabolite production, though direct evidence in humans is…
Yes, encorafenib plus binimetinib is effective for BRAF V600E-mutated thyroid cancer, with a 54.5% objective response rate in a phase 2 trial, including responses in both…
Yes, the Systemic Immune-Inflammation Index (SII) shows moderate diagnostic accuracy for thyroid cancer, with pooled sensitivity of 76.8% and specificity of 71.2% based on a…
Cervical lymphadenitis is the most common presentation of NTM infection in children, occurring in about 90% of cases, especially in those aged 1-2 years.
Diagnosis of Nontuberculous Mycobacterial (NTM) infection in children is often delayed because the infections present with non-specific symptoms and have limited microbiological…
Lung transplant outcomes in NTM patients are generally good with pre-transplant treatment, but post-transplant NTM infection can occur and requires management.
Yes, early evidence suggests transcutaneous auricular vagus nerve stimulation may improve symptoms in some gastrointestinal disorders, especially constipation-predominant IBS…
In athletes, Bifidobacterium longum BB536 did not significantly improve gastrointestinal symptoms overall, though some benefits were seen in specific subgroups.
SGLT2 inhibitors may lower all-cause mortality in transthyretin cardiomyopathy, but evidence is mixed; one study shows benefit, another shows no mortality reduction when added to…
Yes, furosemide plus hypertonic saline is linked to lower increases in biomarkers like NT-proBNP, IL-6, and sST2 after a saline load in ADHF patients, though baseline reductions…
Yes, natriuresis-guided protocols increase weight loss in acute decompensated heart failure, with a meta-analysis showing about 0.45 kg more weight loss at 48 hours compared to…
Evidence is mixed: one meta-analysis found natriuresis-guided protocols shortened hospital stays by about 1 day, but another found no significant difference.
Yes, chemoimmunotherapy improves survival in patients with liver metastases, with benefits similar to those without liver metastases, according to a large meta-analysis.
Yes, robotic surgery appears safe for treating colorectal cancer and liver metastases together in selected patients, with low conversion rates and no reported deaths in early…
Yes, thermal ablation is a safe and effective treatment for small colorectal liver metastases, with low complication rates and survival outcomes comparable to surgery.
Immune checkpoint inhibitors (ICIs) show reduced effectiveness in patients with liver metastases, but combining them with local treatments or certain targeted therapies may…
Yes, Xarelto (rivaroxaban) is FDA-approved for stroke prevention in nonvalvular atrial fibrillation, based on the ROCKET-AF trial showing it is noninferior to warfarin with a…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.